This significant advancement in the understanding of glucagon secretion in T1D requires further characterization, since, as previously noted, it is currently hypothesized that somatostatin mediates the ability of GLP-1 to inhibit glucagon secretion, yet the exact mechanism is unknown. The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.